在一家学术性内科诊所开展的 COVID-19 初期激增期间与 2 型糖尿病相关的健康措施

IF 2.6 4区医学 Q3 ENDOCRINOLOGY & METABOLISM

Primary Care Diabetes Pub Date : 2024-04-01 DOI:10.1016/j.pcd.2024.01.007

Lawrence Ma, Joseph Diaz, Jennifer Deconde, Melissa Wong, Bernice Ruo

引用次数: 0

摘要

COVID-19 大流行扰乱了美国乃至全球的慢性病管理。本研究报告了 COVID-19 最初的大流行对一个学术中心的门诊普通内科 2 型糖尿病患者的体重指数、血压、胆固醇和血糖控制的最小影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Type 2 diabetes-related health measures during the initial COVID-19 surge at an academic internal medicine practice

The COVID-19 pandemic disrupted chronic disease management in the United States and across the world. This study reports minimal effects of the initial COVID-19 surge on body mass index, blood pressure, cholesterol, and blood glucose control in ambulatory general internal medicine patients with Type 2 diabetes at a single academic center.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Primary Care Diabetes ENDOCRINOLOGY & METABOLISM-PRIMARY HEALTH CARE

CiteScore

5.00

自引率

3.40%

发文量

134

审稿时长

47 days

期刊介绍： The journal publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society''s aim of improving the care for people with diabetes mellitus within the primary-care setting.